About Rachel Sha
Rachel Sha is a chief executive officer, board member at Terrestrial Bio.
Form D filings also name Rachel Sha as a director at Lucy Therapeutics, Axoft and Droplet Biosciences.
Rachel Sha first appears on SEC filings in 2023.
Experience
This experience comes from Rachel Sha's profile and from SEC filings. For roles taken from filings, the years are when the filings name Rachel Sha in the role, so the role may have started earlier or lasted longer.
Terrestrial Bio, Inc. Current
Chief Executive Officer, Board Member
2024 – Present · Woburn, MA
Develops patches to deliver medicines through the skin for patients.
TU
Turbine Current
Strategic Advisor
2023 – Present
SL
Sha Consulting, LLC. Current
Independent Consultant / Advisor
2022 – Present
Axoft, Inc.
Director
2023 – 2024 · Cambridge, MA
Develops brain implants intended to help people with neurological disorders.
EV
Engine Ventures
Operating Partner
2023 – 2024
TE
The Engine
Operating Partner
2022 – 2023
SA
Sanofi
Vice President, Digital Strategy, Partnering and Governance
2011 – 2022
GE
Genzyme
Director, Corporate Development
2005 – 2011
NO
Novartis
MBA Intern
2004
AC
Accenture
Manager - Consultant - Analyst
1998 – 2003
Key Colleagues at Startups
The people Rachel Sha works with at each company, as listed on that company's latest Form D.
Terrestrial Bio, Inc. · Form D, Mar 19, 2026
LT
Linda Tussey
Executive officer
KK
Kathryn Kousda
Executive officer and director
Livio Valenti
Executive officer
Ann DeWitt
Director
Fenel Eloi
Managing Partner, P&M Capital Partners, director
Peter Kolchinsky
Co-Founder and Managing Partner, RA Capital Management, director
Lucy Therapeutics, Inc. · Form D/A, May 2, 2024
Axoft, Inc. · Form D, Mar 5, 2024
Droplet Biosciences, Inc. · Form D, Dec 13, 2023
SL
Stanley Lapidus
Director
TT
Theresa Tribble
Chief Executive Officer and director
AD
Ann DeWitt
Director
JZ
Jose Zevallos
Director